期刊文献+

神经源性表皮生长因子样分子-1局部植入促进大鼠长骨干骨折愈合的研究 被引量:2

Local transplantation of neural epidermal growth factor like 1 promoting healing of long bone fracture in rats
原文传递
导出
摘要 目的 观察神经源性表皮生长因子样分子-1(NELL-1)促进大鼠长骨骨折愈合能力,评估骨折愈合过程中断端骨痂形成.方法 制作Sprague-Dawley大鼠桡骨中段骨折动物模型,在骨折断端位置植入含NELL-1/骨形态发生蛋白-2(BMP-2)的β-磷酸钙复合物,术后1、2、3、4周分别行手术部位X线摄片,对骨折愈合和骨痂形成量化分析.t检验比较NELL-1和BMP-2促进骨折愈合评分和骨痂形成评分;方差分析法比较实验组和对照组在不同时间段骨折愈合趋势及骨痂形成趋势.结果 NELL-1和BMP-2都能够很好地促进大鼠桡骨中段骨折愈合,第4周骨折愈合评分达4分者均超过50%,NELL-1和BMP-2促进哺乳动物长骨干部骨折愈合的能力差异无统计学意义(P>0.05);骨折愈合2~3周时,NELL-1组骨痂形成评分均值为2.5分,与BMP组比较差异无统计学意义(P>0.05),在骨折愈合后期(3~4周),NELL-1组形成骨痂评分均值均<1.5分,低于于BMP-2组均值(P<0.05).结论 NELL-1是一种具有可靠促进骨折愈合和新骨生成能力的生物活性蛋白,它在形成较小骨痂的情况下,能发挥与BMP-2相当的促进骨折愈合的能力. Objective To study the effects of neural epidermal growth factor like 1 (NELL-1) on healing of long bone fracture in Sprague-Dawley (SD) rats and observe the callus formation during bone healing period.Methods Mid radius fracture models were established in SD rats.NELL-1/bone morphogenetic protein 2 (BMP-2)-β-tricalcium phosphate (β-TCP) compound was constructed and implanted into the fracture zone.X-ray films were taken at 1st,2nd,3rd,and 4th week after surgery.The bone healing and callus formation were quantitatively analyzed.The t test was used to analyze the differences of bone haling scores and callus formation scores between NELL-1 and BMP-2.Variance analysis was used to evaluate trends of callus formation during bone healing period.Results NELL-1 can perform excellent bone healing ability equal to BMP-2 in mid radius fracture rats model,differences are not significant (P >0.05),Both group had over 50% Bone healing score reached 4 by the end of the 4th week.In first 2-3 weeks,difference of callus formation between NELL-1 and BMP-2 group are of none significance,at an average score 2.5.During late period of bone healing procedure (3-4 weeks),callus of NELL-1 group achieve an average score 1.5,significantly smaller than group using BMP-2 (P < 0.05).Conclusion NELL-1 is a promising bone healing and bone grafting protein that can be carried by β-TCP.As compared with BMP-2,NELL-1 can perform competitive bone healing ability with less callus formation.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2015年第9期2211-2213,共3页 Chinese Journal of Experimental Surgery
关键词 神经源性表皮生长因子样分子-1 骨折愈合 骨痂 Neural epidermal growth factor like 1 Bone healing Bone callus
  • 相关文献

参考文献23

  • 1Carragee E J, Hurwitz EL, Weiner BK. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery:emerging safety concerns and lessons learned [ J ]. Spine J, 2011,11 ( 6 ) : 471 - 491.
  • 2Boraiah S, Paul O, Hawkes D, et al. Complications of recombinant hu-man BMP-2 for treating complex tibial plateau fractnres:a preliminary report[ J]. Clin Orthop Relat Res ,2009,467 (12) :3257-3262.
  • 3Pinel CB, Pluhar GE. Clinical application of recombinant human bone morphogenetic protein in cats and dogs:a review of 13 cases[ J]. Can Vet J,2012,53 (7) :767-774.
  • 4Ting K,Vastardis H,Muniken JB,et al. Human NELL-1 expressed in unilateral coronal synostosis[ J]. J Bone Miner Res, 1999,14 (1) :80- 89.
  • 5Zhang X, Kuroda S, Carpenter D, et al. Craniosynostosis in transgenic mice overexpressing Nell-1 [ J ]. J Clin Invest, 2002, 110 ( 6 ) : 861 - 870.
  • 6Siu RK,Lu SS,Li W,et al. Nell-1 protein promotes bone formation in a sheep spinal fusion model [ J ]. Tissue Eng Part A, 2011,17 (7-8) : 1123-1135.
  • 7Kwak J, Zara JN, Chiang M, et al. NELL-1 injection maintains long- bone quantity and quality in an ovariectomy-induced osteoporotic se- nile rat model[ J]. Tissue Eng Part A ,2013,19 (3-4) :426-436.
  • 8Ohura K, Bohner M, Hardouin P, et al. Resorption of, and bone forma- tion from, new beta-tricalcium phosphate-monocalcium phosphate ce- ments : an in vivo study [ J ]. J Biomed Mater Res, 1996,30 ( 2 ) : 193- 200.
  • 9Li W, Lee M, Whang J, et al. Delivery of lyophilized Nell-1 in a rat spinal fusion model [ J ]. Tissue Eng Part A, 2010, 16 ( 9 ) : 2861- 2870.
  • 10Lee JY, Seol YJ, Kim KH, et al. Transforming growth factor (TGF) - betal releasing triealcium phosphate/chitosan micmgranules as bone substitutes [ J ]. Pharm Res,2004,21 ( 10 ) : 1790-1796.

二级参考文献17

  • 1唐立群,宫明智,刘中浩,司海朋,邢德国,赵敬杰.糖尿病大鼠骨折愈合过程中骨钙素的变化[J].中华实验外科杂志,2006,23(4):617-618. 被引量:15
  • 2邢德国,宫明智,武士清,刘中浩.糖尿病大鼠骨折后血管内皮生长因子的变化[J].中华实验外科杂志,2007,24(4):484-486. 被引量:6
  • 3Gelse K, Schneider H. Ex vivo gene therapy approaches to cartilage re- pair. Advanced Drug Delivery Reviews ,2006,58:259-284.
  • 4Stevens MM, Marini RP, Martin I, et al. FGF-2 enhances TGF-betal- induced periosteal chondrogenesis. J Orthop Res, 2004, 22 : 1114- 1119.
  • 5Gelse K, yon der Mark K, Aigner T, et al. Articular cartilage repair by gene therapy using growth factor-producing mesenchymal cells. Arthri- tis Rheum,2003,48:430-441.
  • 6Palmer GD, Steinert A, Pascher A, et al. Gene-induced chondrogenesis of primary mesenchymal stem cells in vitro. Mol Ther,2005,12:219- 228.
  • 7Park J, Gelse K, Frank S, et al. Transgene-activated mesenchymal cells for articular cartilage repair : a comparison of primary bone marrow-, perichondrium/periosteum-and fat-derived cells. J Gene Med, 2006, 8:112-125.
  • 8Giannoudis PV, Tzioupis CH, Tsirids E. Gene therapy in orthopaedics. Injury,2006,375:530-540.
  • 9Tanaka H, Quarto R, Williams S, et al. In vivo and in vitro effects of insulin-like growth facot-1 ( IGF-1 ) on femoral mRNA expression in old rats. Bone, 2004 : 15 : 647 -553.
  • 10Musgrave DS,Bosch P,Lee JY,et al. Ex vivo gene therapy to produce bone using different cell types. Clin Orthop,2000,378:290-305.

共引文献7

同被引文献15

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部